scispace - formally typeset
G

Gudrun Pregartner

Researcher at Medical University of Graz

Publications -  78
Citations -  863

Gudrun Pregartner is an academic researcher from Medical University of Graz. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 12, co-authored 67 publications receiving 485 citations. Previous affiliations of Gudrun Pregartner include University of Graz.

Papers
More filters
Journal ArticleDOI

Clinical implications of subclonal TP53 mutations in acute myeloid leukemia.

TL;DR: The data suggest that subclonal TP53 mutations are a novel prognostic parameter in acute myeloid leukemia and emphasize the usefulness of next-generation sequencing technologies for risk stratification in this disorder.
Journal ArticleDOI

Implementation of a Surgical Safety Checklist: Interventions to Optimize the Process and Hints to Increase Compliance

TL;DR: Data show that the implementation of new tools such as the adapted WHO SSC needs constant supervision and instruction until it becomes self-evident and accepted.
Journal ArticleDOI

Cytarabine dose in the consolidation treatment of AML: a systematic review and meta-analysis

TL;DR: To the editor: Acute myeloid leukemia (AML) is the most common acute leukemia in adults with an annual, age-adjusted incidence of 3.5/100 000 men and women rising to 15 to 20 above the age of 60 years.
Journal ArticleDOI

Adiponectin Predicts High-Density Lipoprotein Cholesterol Efflux Capacity in Adults Irrespective of Body Mass Index and Fat Distribution

TL;DR: Hypoadiponectemia is a robust predictor of reduced cholesterol efflux capacity in adults irrespective of BMI and fat distribution and further investigations are needed to assess whether adiponectin is a causal determinant of CEC.
Journal ArticleDOI

Does Platelet Reactivity Predict Bleeding in Patients Needing Urgent Coronary Artery Bypass Grafting During Dual Antiplatelet Therapy

TL;DR: A gradual decrease in red blood cell loss and BARC-4 bleeding occurs with increasing platelet reactivity in patients on antiplatelet therapy undergoing CABG, and these findings support current guidelines to determine time of surgery based on an objective measurement of platelet function.